rivastigmine has been researched along with Inflammation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Serie, MM; AlFadly, ED; Bakkar, NZ; Bartolini, M; Belal, ASF; El-Yazbi, AF; Elkazaz, S; Elzahhar, PA; Ghareeb, DA; Iriepa, I; Janockova, J; Kobeissy, F; Moraleda, I; Rafeh, RW; Saudi, MNS; Shaltout, H; Soukup, O; Tramarin, A | 1 |
| Chen, C; Fu, J; Hu, M; Li, X; Shao, S; Shi, G; Wang, D; Wu, S; Zhang, D; Zhang, T; Zhou, Y | 1 |
| Hoe, HS; Jeong, HR; Kim, J; Lee, H; Lee, HJ; Lee, S; Park, JH; Park, SK; Seol, E | 1 |
| Cucos, CA; Dobre, M; Dragnea, EM; Manda, G; Milanesi, E | 1 |
| Coutinho-Silva, R; Dos Santos, TM; Leite-Aguiar, R; Ramires Junior, OV; Savio, LEB; Silveira, JS; Wyse, ATS | 1 |
| Mehrabadi, S; Moradbeygi, K; Motevaseli, E; Sadr, SS | 1 |
| Antushevich, H; Bochenek, J; Haziak, K; Herman, A; Herman, AP; Krawczyńska, A; Misztal, T; Romanowicz, K; Tomaszewska-Zaremba, D | 1 |
| Tang, XC; Wang, J; Zhang, HY | 1 |
| Agrawal, R; Nath, C; Shukla, R; Tyagi, E | 1 |
1 review(s) available for rivastigmine and Inflammation
| Article | Year |
|---|---|
Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.
Topics: Acetylcholine; Alkaloids; Animals; Anti-Inflammatory Agents; Cholinergic Agents; Cholinesterase Inhibitors; Dementia, Vascular; Disease Models, Animal; Donepezil; Galantamine; Humans; Indans; Inflammation; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, Cholinergic; Rivastigmine; Sesquiterpenes; Signal Transduction | 2009 |
1 trial(s) available for rivastigmine and Inflammation
| Article | Year |
|---|---|
The effect of rivastigmine on the LPS-induced suppression of GnRH/LH secretion during the follicular phase of the estrous cycle in ewes.
Topics: Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Down-Regulation; Estrous Cycle; Female; Follicular Phase; Gene Expression; Gonadotropin-Releasing Hormone; Hypothalamus; Inflammation; Injections, Subcutaneous; Lipopolysaccharides; Luteinizing Hormone; Phenylcarbamates; Pituitary Gland; Rivastigmine; Sheep, Domestic | 2013 |
7 other study(ies) available for rivastigmine and Inflammation
| Article | Year |
|---|---|
Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase.
Topics: Acetylcholine; Alzheimer Disease; Animals; Cell Line; Cholinesterase Inhibitors; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; Inflammation; Lipoxygenase Inhibitors; Mice; Molecular Docking Simulation; Neurons; PC12 Cells; Rats; Semicarbazides; Triazoles | 2019 |
Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Blood-Brain Barrier; Butyrylcholinesterase; Cell Line; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Inflammation; Isoflavones; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Models, Molecular; Molecular Structure; Neuroprotective Agents; Receptors, Histamine H3; Structure-Activity Relationship | 2019 |
Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Cells, Cultured; Cholinesterase Inhibitors; Cytokines; Disease Models, Animal; Donepezil; Inflammasomes; Inflammation; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mitogen-Activated Protein Kinases; NLR Family, Pyrin Domain-Containing 3 Protein; Rivastigmine; STAT3 Transcription Factor | 2021 |
Increased MYD88 blood transcript in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Disease Progression; Humans; Inflammation; Mice; Mice, Transgenic; Myeloid Differentiation Factor 88; Rivastigmine | 2022 |
Rivastigmine Reverses the Decrease in Synapsin and Memory Caused by Homocysteine: Is There Relation to Inflammation?
Topics: Acetylcholinesterase; Animals; Homocysteine; Hyperhomocysteinemia; Ibuprofen; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Rivastigmine; Synapsins | 2022 |
Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 expression in model of Alzheimer's disease rats.
Topics: Adipose Tissue; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cholinesterase Inhibitors; Culture Media, Conditioned; Disease Models, Animal; Hippocampus; Hypoxia; Inflammation; Interleukin-1beta; Learning; Male; Maze Learning; Mesenchymal Stem Cells; Peptide Fragments; Rats; Rats, Wistar; Recognition, Psychology; Rivastigmine; Spatial Memory; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2020 |
Effect of anti-dementia drugs on LPS induced neuroinflammation in mice.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Brain; Cholinesterase Inhibitors; Dementia; Donepezil; Dose-Response Relationship, Drug; Indans; Inflammation; Injections, Intraperitoneal; Interleukin-2; Lipopolysaccharides; Mice; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine | 2007 |